Heart News and Research

RSS

University of California San Diego launches new center to help conduct meaningful research in real-world settings

Throughout the history of medicine and science, researchers have frequently discovered evidence of promising ways to improve health outcomes for patients and communities -- only to have those findings languish in papers published in scientific journals.

17 Jul 2020

Researchers unravel key mechanisms behind the mysteries of aging

Molecular biologists and bioengineers at the University of California San Diego have unraveled key mechanisms behind the mysteries of aging. They isolated two distinct paths that cells travel during aging and engineered a new way to genetically program these processes to extend lifespan.

16 Jul 2020

Common blood test could advance life-saving treatment for heart failure

Biomedical experts believe that half of heart failure patients likely have low levels of the thyroid hormone T3 in their cardiac tissue.

16 Jul 2020

Discovery hints at novel therapeutic target for Ewing sarcoma

New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature. Researchers from the Long School of Medicine at The University of Texas Health Science Center at San Antonio contributed to the study.

16 Jul 2020

A new strategy to combat treatment resistance in choroidal neovascularization

An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), an aggressive form of age-related macular degeneration, the leading cause of irreversible blindness in the elderly.

16 Jul 2020

UTHSC researchers receive $2.4 million to study the role of cholesterol in brain artery health

Alex Dopico, MD, PhD, professor and Van Vleet Chair of Excellence in the Department of Pharmacology, Addiction Science, and Toxicology, and Anna Bukiya, PhD, associate professor in the Department of Pharmacology, Addiction Science, and Toxicology, have been awarded $2.4 million from the National Heart, Lung, and Blood Institute to explore how cholesterol interacts with the mechanisms that modulate blood vessel function in the brain.

16 Jul 2020

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.

16 Jul 2020

Why doctors keep monitoring kids who recover from mysterious COVID-linked illness

Israel Shippy doesn’t remember much about having COVID-19 — or the unusual auto-immune disease it triggered — other than being groggy and uncomfortable for a bunch of days. He’s a 5-year-old, and would much rather talk about cartoons, or the ideas for inventions that constantly pop into his head.

16 Jul 2020

Multiple social disadvantages can amplify stroke risk, study shows

Having more social disadvantages can nearly triple your risk of stroke, particularly if you are under the age of 75, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

16 Jul 2020

Study: Rate of recurrent strokes is significantly declined among Mexican Americans

The rate of recurrent strokes significantly declined among Mexican Americans in a long-term study, according to new research published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

16 Jul 2020

Study could accelerate drug development to reduce age-related diseases

Genes linked to ageing that could help explain why some people age at different rates to others have been identified by scientists.

16 Jul 2020

Researchers solve the mystery of genetic defect in horses

Warmblood fragile foal syndrome is a severe, usually fatal, genetic disease that manifests itself after birth in affected horses.

16 Jul 2020

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Statins are a class of drugs often used to control high cholesterol levels in obesity. Now, a study published on the preprint server medRxiv* in July 2020 suggests that statins do not aggravate the risk of COVID-19 infection and may have a small beneficial effect in some cases.

16 Jul 2020

AHA’s Scientific Sessions 2020 goes virtual in light of COVID-19 pandemic

After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic.

16 Jul 2020

Children with MIS-C have different antibody responses than adults with COVID-19

A new study published on the preprint medRxiv in July 2020 reveals that children with the condition Multisystem Inflammatory Syndrome in Children (MIS-C) have a distinctly different pattern of antibody generation compared to adults with COVID-19 disease.

16 Jul 2020

Peptide-derived nanoparticle drug shows promise for treating heart attack

Researchers at the University of Illinois at Chicago have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available.

15 Jul 2020

Researchers 3D-print a functioning human heart pump in the lab

In a groundbreaking new study, researchers at the University of Minnesota have 3D printed a functioning centimeter-scale human heart pump in the lab.

15 Jul 2020

COVID-19 rates among health care workers drop at Mass General Brigham after universal masking

In March of 2020, Mass General Brigham implemented a new policy: everyone working at the hospitals would be required to wear a surgical mask.

15 Jul 2020

MRI can be used to predict major cardiac events for people with dilated cardiomyopathy

Heart Failure impacts between three to four per cent of the general population. While commonly related to heart attacks it can also be due to a condition called dilated cardiomyopathy (DCM), a disease characterized by an enlarged and weak heart muscle that can't efficiently pump blood.

15 Jul 2020

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.

15 Jul 2020